Navigation

Assure
  • Patients
  • Physicians
  • Hospitals
  • Procedures
  • Career
  • About Us
    • About IONM
    • Leadership
  • Investor Info
  • Contact

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Media
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Financial Results
    • SEDAR
  • Stock Info
    • OTCQB: ARHH
    • TSXV: IOM
    • Analyst Coverage
  • Governance
    • Board of Directors
    • Governance Documents
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Media
  • Email Alerts

Assure Holdings Announces Resignation of Auditors, Delayed Filing of Audited Financial Statements and MD&A for 2017, Resignation of Matthew Willer as a Director, Launches Special Independent Investigation and Application to File Management Cease Trade Order

Mar 12, 2018 8:30am EDT

Assure Holdings Adds New Surgeon Partner in Texas and Performs First Case

Mar 07, 2018 8:30am EST

Assure Holdings to Present at the 30th Annual ROTH Conference on March 13, 2018

Mar 06, 2018 8:30am EST

Assure Holdings Corp. Announces Graduation to Tier 1 TSXV Listing

Feb 27, 2018 8:30am EST

Assure Holdings to Present at the 2018 World Outlook Financial Conference

Feb 01, 2018 8:30am EST

Assure Holdings Performs First Neuromonitoring Case in Louisiana

Jan 30, 2018 8:30am EST

Assure Holdings Corp. Names Alex Rasmussen as Executive Vice President of Operations

Jan 24, 2018 8:30am EST

Assure Holdings Appoints Peter Csapo as Chief Financial Officer

Jan 16, 2018 8:30am EST

Assure Holdings Reports Strong Third Quarter 2017 Results

Nov 30, 2017 4:05pm EST

Assure Holdings Sets Third Quarter 2017 Conference Call for Thursday, November 30, 2017 at 5:00 p.m. ET

Nov 21, 2017 4:05pm EST
RSS
  • Prev
    • 1...
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • 12
    • 13
    Next
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed

    Find our list of procedures.

    Click Here
    Assure

    Contact Us

    Assure Neuromonitoring

    4600 South Ulster Street, Suite 1225

    Denver, CO 80237

    Patient Advocate Line

    Toll Free: 1-800-570-8413

    Local: 303-515-7179

    Office Number

    Call us: 720-287-3093

    Toll Free: (877) 208-1373

    Footer

    Notice of Privacy Practices

    ©2021 - Assure Neuromonitoring, LLC. | All rights reserved